院外心脏骤停后早期大剂量维生素C:VITaCCA随机临床试验
该双盲、多中心、2期试验将院外心脏骤停(可除颤心律)复苏后昏迷成人随机分为安慰剂组、补充剂量(3 g)组和超生理剂量(10 g)组,每日静脉给药共96 h。主要终点为96 h复苏-序贯器官衰竭评估(R-SOFA)评分变化。273例纳入主要分析(安慰剂93例、3 g组91例、10 g组89例),96 h R-SOFA评分平均变化分别为-3.2、-2.3和-0.8(总体差异P=0.04)。10 g组较安慰剂组R-SOFA改善少2.5分(95%CI 0.5-4.5;P=0.01),并导致肌钙蛋白T释放更高、肾功能更差和神经功能结局更差。
要点
- 院外心脏骤停复苏后昏迷成人每日静脉维生素C 3 g或10 g共96 h,未减轻96 h器官功能障碍。
- 10 g维生素C组96 h R-SOFA评分较安慰剂组改善少2.5分(95%CI 0.5-4.5;P=0.01)。
- 10 g维生素C组较3 g组R-SOFA评分改善少1.6分(95%CI -0.4至3.6;P=0.12),未达统计学显著。
- 10 g维生素C导致肌钙蛋白T释放更高、肾功能更差和神经功能结局更差。
- 安慰剂组、3 g组和10 g组96 h R-SOFA评分平均变化分别为-3.2、-2.3和-0.8(总体差异P=0.04)。
适用人群与场景
- 院外心脏骤停(可除颤心律)复苏后昏迷的成人患者。
处置流程与药物剂量
- 安慰剂、补充剂量(3 g)或超生理剂量(10 g)维生素C每日静脉给药,共96 h。
研究设计与关键结果
- 双盲、多中心、2期试验,273例纳入主要分析(安慰剂93例、3 g组91例、10 g组89例)。
- 主要终点96 h R-SOFA评分平均(SD)变化:安慰剂组-3.2(5.7)、3 g组-2.3(7.4)、10 g组-0.8(7.6),总体差异P=0.04。
- 10 g维生素C组较安慰剂组R-SOFA评分改善少2.5分(95%CI 0.5-4.5;P=0.01)。
- 10 g维生素C组较3 g组R-SOFA评分改善少1.6分(95%CI -0.4至3.6;P=0.12)。
- 10 g维生素C组肌钙蛋白T释放更高、肾功能更差、神经功能结局更差。
证据类型、等级与局限
- 证据类型:双盲、多中心、2期随机对照试验(NCT03509662)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 院外心脏骤停复苏后昏迷患者每日静脉给予维生素C 10 g共96 h未减轻96 h器官功能障碍,反而恶化器官功能结局。
- 作者认为,在院外心脏骤停患者中,静脉维生素C未减少96 h器官功能障碍,10 g组甚至恶化了器官功能结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Besides temperature management, there is currently no effective therapy to decrease the burden of post-cardiac arrest syndrome. The pleiotropic effects of vitamin C may improve clinical outcome.
PURPOSE: This trial investigated whether early administration of 3 g or 10 g intravenous vitamin C attenuated organ dysfunction post-cardiac arrest.
METHODS: In this double-blind, multi-center, phase 2 trial, comatose adults resuscitated from shockable out-of-hospital cardiac arrest randomly received intravenously placebo, supplementary (3 g) or supraphysiological dose (10 g) vitamin C daily for 96 h. The primary endpoint was the 96 h change in the resuscitation-sequential organ failure assessment (R-SOFA) score. Secondary endpoints included neurological outcome, myocardial injury, vasopressor- and ventilator-free days, renal function, ICU-acquired weakness, delirium, length of ICU and hospital stay, and 28- and 180-day mortality.
RESULTS: 273 patients (93 on placebo, 91 on 3 g and 89 on 10 g) were included in the primary analysis. Mean (SD) change in R-SOFA score at 96 h was - 3.2 (5.7) in the placebo group, - 2.3 (7.4) in the 3 g group, and - 0.8 (7.6) in the 10 g group (p = 0.04 for overall difference). 10 g vitamin C resulted in 2.5 points less improvement in R-SOFA score compared with placebo (95% CI 0.5-4.5; p = 0.01), and 1.6 points less improvement compared with 3 g vitamin C (95% CI - 0.4 to 3.6; p = 0.12). Vitamin C 10 g led to higher troponin T release, worse renal function and worse neurological outcomes.
CONCLUSION: In out-of-hospital cardiac arrest patients, intravenous vitamin C did not reduce organ dysfunction at 96 h, but even worsened organ function outcomes in the 10 g group.
TRIAL REGISTRATION: NCT03509662.
参考来源
- Rozemeijer S, Dubois EA, de Grooth HJ, et al. Early high-dose vitamin C for out-of-hospital cardiac arrest: the VITaCCA randomized clinical trial. Intensive Care Med. 2026. PMID: 42301311. doi:10.1007/s00134-026-08492-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。